Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MHC-antigen-T cell interactions: an overview.

A Sette1, D O'Sullivan, J I Krieger

  • 1Centocor Corporation, Malvern, PA 19355.

Seminars in Immunology
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction.

ESC heart failure·2024
Same author

Daily opioid and stimulant co-use and nonfatal overdoses in the context of social disadvantage: Findings on marginalized populations.

Journal of substance use and addiction treatment·2023
Same author

Immune signatures underlying post-acute COVID-19 lung sequelae.

Science immunology·2021
Same author

Therapeutic anti-coagulation in COVID-19 and the potential enhanced risk of retroperitoneal hematoma.

QJM : monthly journal of the Association of Physicians·2021
Same author

Pathways to post-traumatic growth in cancer patients: moderated mediation and single mediation analyses with resilience, personality, and coping strategies.

Journal of affective disorders·2020
Same author

An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.

Vaccine·2020

We developed assays to study how synthetic peptides bind to HLA class II molecules. This research explores using peptide competition to treat T cell-mediated autoimmune diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Understanding peptide-MHC class II interactions is crucial for immunology.
  • Current methods for studying these interactions have limitations.

Purpose of the Study:

  • To establish and validate direct assays for measuring synthetic peptide and HLA class II molecule interactions.
  • To define structural requirements for peptide-class II molecule binding.
  • To explore the therapeutic potential of modulating these interactions in autoimmune diseases.

Main Methods:

  • Development and validation of direct biochemical and biological assays.
  • Utilizing random screening, sequence analysis, and site-directed mutagenesis.
  • In vivo studies to assess therapeutic strategies.

Related Experiment Videos

Main Results:

  • Successful establishment and validation of direct assays for peptide-HLA class II interactions.
  • Identification of structural requirements governing peptide binding to HLA class II molecules.
  • In vivo evidence supporting the potential of peptide competition in treating T cell-mediated autoimmune diseases.

Conclusions:

  • Direct assays provide a robust method for studying peptide-HLA class II interactions.
  • Structural insights can guide the development of therapeutic peptides.
  • Peptide competition represents a promising strategy for autoimmune disease treatment.